Marshall Wace North America’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	$1.23M	Buy	+75,000	New	+$1.23M	0.01%	833
2018 Q2	–	Sell	-807	Closed	-$85K	–	1709
2018 Q1	$85K	Buy	+807	New	+$85K	﹤0.01%	1372